These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 7921597)

  • 41. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
    de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
    Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostaglandin E2 may induce hyperthermia through EP1 receptor in the anterior wall of the third ventricle and neighboring preoptic regions.
    Oka K; Oka T; Hori T
    Brain Res; 1997 Aug; 767(1):92-9. PubMed ID: 9365020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2 alpha in conscious mice.
    Minami T; Nishihara I; Ito S; Sakamoto K; Hyodo M; Hayaishi O
    Pain; 1995 May; 61(2):285-290. PubMed ID: 7659439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Ishikawa I
    J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice.
    Uda R; Horiguchi S; Ito S; Hyodo M; Hayaishi O
    Brain Res; 1990 Feb; 510(1):26-32. PubMed ID: 2322844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Umeda M; Izumi Y; Murota S; Ishikawa I
    Inflammation; 2001 Apr; 25(2):75-81. PubMed ID: 11321362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors.
    Yokotani K; Nishihara M; Murakami Y; Hasegawa T; Okuma Y; Osumi Y
    Br J Pharmacol; 1995 Jun; 115(4):672-6. PubMed ID: 7582489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production.
    Caggiano AO; Kraig RP
    J Neurochem; 1999 Feb; 72(2):565-75. PubMed ID: 9930728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostaglandin E-type receptor subtypes and gastroduodenal bicarbonate secretion in rats.
    Takeuchi K; Yagi K; Kitamura M; Kubomi M; Tashima KI
    J Gastroenterol Hepatol; 1998 Nov; 13(S3):S221-S226. PubMed ID: 28976658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes.
    Brochhausen C; Neuland P; Kirkpatrick CJ; Nüsing RM; Klaus G
    Arthritis Res Ther; 2006; 8(3):R78. PubMed ID: 16646980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells.
    Zeng L; An S; Goetzl EJ
    Immunology; 1995 Dec; 86(4):620-8. PubMed ID: 8567030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL.
    Schwaner I; Offermanns S; Spicher K; Seifert R; Schultz G
    Biochim Biophys Acta; 1995 Feb; 1265(1):8-14. PubMed ID: 7532011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
    Wang XS; Lau HY
    Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2.
    Ono K; Akatsu T; Murakami T; Nishikawa M; Yamamoto M; Kugai N; Motoyoshi K; Nagata N
    J Endocrinol; 1998 Sep; 158(3):R1-5. PubMed ID: 9846175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes.
    Konger RL; Malaviya R; Pentland AP
    Biochim Biophys Acta; 1998 Feb; 1401(2):221-34. PubMed ID: 9531979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes.
    Kunikata T; Araki H; Takeeda M; Kato S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):157-63. PubMed ID: 11595431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin E receptor subtypes in mouse osteoblastic cell line.
    Suda M; Tanaka K; Natsui K; Usui T; Tanaka I; Fukushima M; Shigeno C; Konishi J; Narumiya S; Ichikawa A; Nakao N
    Endocrinology; 1996 May; 137(5):1698-705. PubMed ID: 8612504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes.
    Asbóth G; Phaneuf S; Europe-Finner GN; Tóth M; Bernal AL
    Endocrinology; 1996 Jun; 137(6):2572-9. PubMed ID: 8641211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.